Nautilus Biotechnology Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for Nautilus Biotechnology stock have an average target of 3.58, with a low estimate of 1.75 and a high estimate of 6.00. The average target predicts an increase of 331.27% from the current stock price of 0.83.

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$1.75	$3.58	$3.00	$6.00
Change	+110.82%	+331.27%	+261.40%	+622.80%

* Price targets were last updated on Dec 5, 2024.

Analyst Ratings

The average analyst rating for Nautilus Biotechnology stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	1	1	1	1	1	1
Buy	0	0	0	0	0	0
Hold	2	2	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	1	1	1	1
Total	3	3	3	3	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Matthew Sykes Goldman Sachs	Goldman Sachs	Hold → Strong Sell Downgrades $2.25 → $1.75	Hold → Strong Sell	Downgrades	$2.25 → $1.75	+110.82%	Dec 5, 2024
Subbu Nambi Guggenheim	Guggenheim	Strong Buy Initiates $6	Strong Buy	Initiates	$6	+622.80%	Jun 27, 2024
Tycho Peterson Jefferies	Jefferies	Strong Buy → Hold Initiates $5 → $3	Strong Buy → Hold	Initiates	$5 → $3	+261.40%	Jun 3, 2024
Tejas Savant Morgan Stanley	Morgan Stanley	Hold Reiterates $6	Hold	Reiterates	$6	+622.80%	Aug 3, 2023
Tejas Savant Morgan Stanley	Morgan Stanley	Hold Maintains $8 → $6	Hold	Maintains	$8 → $6	+622.80%	Aug 3, 2022

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 67.12M

Revenue Next Year

n/a

EPS This Year

-0.60

from -0.56

EPS Next Year

-0.73

from -0.60

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028	FY 2029
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028	Dec 31, 2029
Revenue	3.58M	26.69M	15.86M	29.68M	67.12M
Revenue Growth	-	646.04%	-40.58%	87.17%	126.12%	-	-	-
EPS	-0.54	-0.60	-0.46	-0.51	-0.56	-0.60	-0.73	-0.66
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	7	7	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	7.5M	45.4M	21.6M
Avg	3.6M	26.7M	15.9M
Low	n/a	10.3M	10.3M

Revenue Growth

Revenue Growth	2025	2026	2027
High	-88.8%	1,170.3%	-19.0%
Avg	-94.7%	646.0%	-40.6%
Low	-	187.7%	-61.4%

EPS Forecast

EPS	2025	2026	2027
High	-0.58	-0.64	-0.60
Avg	-0.60	-0.73	-0.66
Low	-0.66	-0.82	-0.72

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.